Health and Healthcare
AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday
Published:
Last Updated:
Earnings season is now in full swing, and we have put together a preview of some of the world’s largest biotechnology and pharmaceutical companies reporting their earnings on Thursday. With the markets running red-hot right now, it is no doubt that health care stocks are some that can benefit the most from this rising tide.
Over the past five, 10 and 20 years, the life sciences and bioproduction segments have outperformed the S&P 500 more often than not. Recently, we took a look at what one key analyst had to say about other companies in this segment that could continue to outperform the broad markets going forward.
Here we have included the Thomson Reuters consensus estimates for each stock, as well as some color and a recent trading history and consensus target for each stock.
AbbVie Inc. (NYSE: ABBV) is scheduled to report its first-quarter results before the markets open. The consensus estimates are $1.26 in earnings per share (EPS) and $6.48 billion in revenue. Shares were last seen at $65.88. The consensus price target is $71.28, and the 52-week range is $55.06 to $68.12.
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) also is set to share its latest quarterly earnings in the morning. The consensus estimates call for a $1.23 in EPS on $827.2 million in revenue. Shares were at $122.88 on Wednesday, in a 52-week range of $109.12 to $157.02. The consensus price target is $161.70.
Bristol-Myers Squibb Co. (NYSE: BMY) is expected to reveal its first-quarter results early in the day as well. The consensus forecast calls for $0.74 in EPS and $4.72 billion in revenue. The stock recently traded at $54.59. The consensus price target is $55.76, and the 52-week range is $46.01 to $77.12.
And Celgene Corp. (NASDAQ: CELG) also will to share its latest quarterly earnings Thursday morning. The consensus estimates call for $1.64 in EPS and $3.04 billion in revenue. Shares were last trading at $125.85, in a 52-week range of $94.42 to $127.64. The consensus price target is $140.04.
100 Million Americans Are Missing This Crucial Retirement Tool
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
